Twelve Long-Term Care Providers End Methadone Admission Bans

Pennsylvania's Attorney General secured agreements requiring individualized assessment of prospective residents taking prescribed opioids.

Updated on Nov. 17, 2026 in Substance Abuse

Bold flat-color editorial illustration of a plain brick institutional building facade with an open doorway, set against a rolling hillside under overcast skies.
Pennsylvania's Attorney General secured agreements from twelve long-term care providers operating over 200 facilities to stop automatically denying admission to residents who take prescribed medications such as methadone. AI Illustration. Upload story photo >

Live Poll

Should nursing homes be barred from refusing patients solely for prescribed medication?

Twelve long-term care providers operating more than 200 facilities agreed to stop automatically denying admission to applicants because they use prescribed medications such as methadone. The agreements, announced by Pennsylvania's Office of Attorney General in Harrisburg, require nursing homes and rehabilitation facilities to evaluate each prospective resident individually.

Why it matters

The agreements follow a 2024 complaint alleging disability discrimination in admission decisions, and they extend individualized assessment requirements across the participating companies' facilities. Residents in Pennsylvania who rely on prescribed medication for chronic pain may face fewer categorical barriers to rehabilitative care.

The agreements cover twelve companies with more than 200 facilities, and the underlying complaint involved a patient who had used methadone under physician supervision for about 20 years. The number of denials affected by the previous practice and the enforcement mechanisms for the agreements were not addressed in the source.

The players

Attorney General Dave Sunday

Dave Sunday is the Pennsylvania Attorney General whose office announced the agreements and conducted the civil rights investigation.

Pennsylvania Office of Attorney General

The Pennsylvania Office of Attorney General is the state's chief law enforcement agency, which investigated the admission practices and negotiated the agreements.

The details

The Pennsylvania Office of Attorney General's Civil Rights Enforcement Section examined the admission policies of facilities accused of rejecting a patient whose methadone was prescribed to manage chronic pain tied to fibromyalgia and Raynaud's syndrome. The complainant's mother reportedly encountered repeated barriers after falling, breaking her hip and being hospitalized twice, and numerous providers allegedly refused admission because of the prescription.

Timeline

  1. 2024: A complaint was filed involving a Westmoreland County woman whose mother allegedly faced admission barriers.

  2. November 17, 2026: The Attorney General announced agreements with twelve providers.

Legal Context

The agreements enforce obligations under the Americans with Disabilities Act and the Pennsylvania Human Relations Act, applying their disability protections to admission decisions for residents who take prescribed opioid medications. The settlements show state enforcement of those statutes in the long-term care sector.

Individuals who take prescribed methadone or similar medications for chronic pain may now have their applications evaluated individually by participating facilities rather than rejected automatically. Families seeking rehabilitative or long-term care placement should ask providers directly how they assess applicants on prescribed opioid therapy.

The takeaway

Patients on long-term prescribed medication should ask prospective facilities how they evaluate applicants, since individualized review is now the stated standard for these twelve providers. Documenting prescriptions and treatment history in advance can help speed that evaluation.

Further reading

For related coverage of medication-assisted treatment, see Substance Abuse reporting from across Pennsylvania.

Live Poll

Should nursing homes be barred from refusing patients solely for prescribed medication?